Skip to main content

WELCOME

CAMP PODS is a webinar series, consisting of nine one-hour sessions that will take place from February to November 2024 on the 1st Thursday of each month.

The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed.  Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.

Overall Learning Objectives:

By the end of the webinar series, an audience member will:

  1. Establish a strong Oncology Education Network
  2. Compare ideas, thoughts and common challenges
  3. Identify gaps and find team solutions for improving patient care
  4. Integrate pathology and oncology practices

OUR NEXT CAMP PODS SESSION

Thursday, March 7th, 2024
10:00am – 10:45am PST Application of Next Generation Molecular Methods for the Detection of Microbial Agents in Pathology Dr. Gregor Gorkiewicz, MD
Vice Chair,
Institute of Pathology
Associate Professor,
Medical University of Graz
Graz, Austria
10:45am  – 11:00am PST Questions & Answers
Learning objectives:
1. Compare various molecular techniques used in infectious diseases.
2. Assess the suitability of tissue samples for molecular identification of pathogens.
3. Describe the role of the molecular pathologist in infectious disease diagnosis and treatment.

OUR LAST CAMP PODS SESSION

Thursday, February 1st, 2024
10:00am – 10:45am PST Application of Immunohistochemistry and Molecular Diagnostics for Melanocytic Tumors in Routine Practice Aleodor (Doru) Andea, MD, MBA
Professor of Oncology
Chief of Dermatopathology
Director of Molecular Dermatopathology
Department of Pathology
Roswell Cancer Comprehensive Cancer Center
Buffalo, NY
10:45am  – 11:00am PST Questions & Answers
Learning Objectives:

  1. Describe the recent advances in the molecular biology of melanocytic tumors and apply that knowledge in routine practice
  2. Determine appropriate immunohistochemical markers that are useful in the diagnosis of melanocytic tumors
  3. Determine appropriate molecular studies that are useful in the diagnosis of melanocytic tumors